<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: topical application</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Discovery of novel medicine for treatment of chronic wounds</title>
   	 <description>Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis Yue Shen from the Industrial Doctoral School and the Department of Medical Biochemistry and Biophysics at Umeå University presented a novel medicine for chronic wound treatment that may completely change the lives of millions of patients.</description>
     <link>http://medicalxpress.com/news/2013-05-discovery-medicine-treatment-chronic-wounds.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 20 May 2013 07:20:03 EST</pubDate>
	 <guid isPermaLink="false">news288252654</guid>
	 
</item>
<item>
     <title>Novel approach found for treating hypertrophic scars</title>
   	 <description>(HealthDay)—Same-session therapy with fractional ablative laser treatment followed immediately with topical application of triamcinolone acetonide suspension is effective in treating patients with hypertrophic and restrictive cutaneous scars, according to research published in the March issue of Lasers in Surgery and Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-approach-hypertrophic-scars.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 27 Mar 2013 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news283605841</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-novelapproac.jpg" width="90" height="90" />
</item>
<item>
     <title>Topical simvastatin shown to accelerate wound healing in diabetes</title>
   	 <description>Delayed wound healing is a major complication of diabetes because the physiological changes in tissues and cells impair the wound healing process. This can result in additional disease outcomes such as diabetic foot ulcer, a significant cause of morbidity in the growing population of diabetic patients. A new study has found that topically applied simvastatin accelerates wound healing in diabetic mice, suggesting important implications for humans with diabetes. This study is published in the December issue of The American Journal of Pathology.</description>
     <link>http://medicalxpress.com/news/2012-11-topical-simvastatin-shown-wound-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 27 Nov 2012 12:50:55 EST</pubDate>
	 <guid isPermaLink="false">news273243030</guid>
	 
</item>
<item>
     <title>Autism treatment is more than skin deep</title>
   	 <description>Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism. Their work is published online in Springer's Journal of Medical Toxicology.</description>
     <link>http://medicalxpress.com/news/2012-11-autism-treatment-skin-deep.html</link>
	 <category>Autism spectrum disorders</category>
	 <pubDate>Tue, 13 Nov 2012 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news272034121</guid>
	 
</item>
<item>
     <title>Protein inhibitor points to potential medical treatments for skull and skin birth defects</title>
   	 <description>Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome (BSS). Using a mouse model, investigators found that by inhibiting the protein p38, previously associated with cancer and certain autoimmune conditions, they were able to interrupt development of specific birth defects associated with it: craniosynostosis, or the premature fusion of certain bones of the skull, and acanthosis nigricans, a hyperpigmentation skin disorder that often makes the skin look dirty and rough.</description>
     <link>http://medicalxpress.com/news/2012-05-protein-inhibitor-potential-medical-treatments.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Tue, 15 May 2012 12:00:07 EST</pubDate>
	 <guid isPermaLink="false">news256299828</guid>
	 
</item>
<item>
     <title>Topical treatment may prevent melanoma</title>
   	 <description>While incidents of melanoma continue to increase despite the use of sunscreen and skin screenings, a topical compound called ISC-4 may prevent melanoma lesion formation, according to Penn State College of Medicine researchers.</description>
     <link>http://medicalxpress.com/news/2011-04-topical-treatment-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 26 Apr 2011 09:40:15 EST</pubDate>
	 <guid isPermaLink="false">news223029593</guid>
	 
</item>


</channel>
</rss>
